Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Roger A. Babb who wrote (2964)	6/11/1998 11:35:00 PM
From: Quad Sevens	Read Replies (1) \| Respond to of 5736

Roger: 20 to 30 for an 8 buck test sounds reasonable for hospital robbery. Lets say $5/test is accessible to CCSI. If that 5 bucks is split 50-50 with CCSI's partner, we get 2.50/test for CCSI. Multiply by 16 million and you arrive at 40 million as a total potential market for CCSI. We have 15 million outstanding shares, so a market cap of 120 million. Of course, the 40 million assumes 100% saturation--impossible. But: We're only counting the U.S. You can safely triple that for the world. Hmmmm ... count the machines themselves, although nonrecurring, and remember margins should be exemplary on the razor blades. Take into account extra tests and added value due to noninvasiveness: that 5 bucks needs to be bumped up. Also, health-device companies get high PEs typically. Just whistlin in the dark, but I don't have a problem with a higher valuation for CCSI here. Wade